Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial

Overview of attention for article published in Gut, February 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#16 of 7,433)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 62 news outlets
twitter: 696 X users

facebook: 1 Facebook page
reddit: 4 Redditors

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 51 Mendeley

Summary News X Facebook Reddit Dimensions citations

So far, Altmetric has seen 4 Reddit threads by 4 users.

How much famotidine y’all taking?

User Happy-Asparagus3258, in the covidlonghaulers subreddit, 14 Feb 2023

Positive March '22 study on Pepcid AC for Covid infection: Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial

User BillyGrier, in the covidlonghaulers subreddit, 31 Mar 2022

Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial

User Alex3917, in the COVID-19 Stack: Research and discussion on supplements and medications relating to COVID-19 subreddit, 03 Mar 2022

Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial

User icloudbug, in the COVID-19 subreddit, 02 Mar 2022

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.